Zobrazeno 1 - 10
of 56
pro vyhledávání: ''
Publikováno v:
Journal of Allergy and Clinical Immunology. 136:245-251
Nonsteroidal anti-inflammatory drug (NSAID)-induced urticarial and angioedema reactions are among the most commonly encountered drug hypersensitivity reactions in clinical practice. Three major clinical phenotypes of NSAID-induced acute skin reaction
Autor:
Daniel L. Hamilos
Publikováno v:
Journal of Allergy and Clinical Immunology. 128:693-707
Chronic rhinosinusitis (CRS) affects 12.5% of the US population. On epidemiologic grounds, some association has been found between CRS prevalence and air pollution, active cigarette smoking, secondhand smoke exposure, perennial allergic rhinitis, and
Autor:
Henry J. Legere, Samridhi N. Nallamshetty, Mariana Castells, F. Ida Hsu, Ursula A. Matulonis, Jayanti J. Rao, Nora A. Barrett, David E. Sloane, Suzanne Berlin, Tanya M. Laidlaw, Nichole M. Tennant, Ross I. Palis, David I. Hong, Susana M. Campos
Publikováno v:
Journal of Allergy and Clinical Immunology. 122:574-580
Background Hypersensitivity reactions (HSRs) to chemotherapeutic drugs, including mAbs, often require that the provoking medication be discontinued, thus raising a dilemma for the caregiver: further use could precipitate a severe, even fatal, allergi
Publikováno v:
Journal of Allergy and Clinical Immunology. 119:1430-1437
Fluticasone furoate (USAN-approved name) is a novel, enhanced-affinity glucocorticoid administered in a unique side-actuated device for the management of seasonal allergic rhinitis (SAR).We sought to evaluate the efficacy and safety of once-daily flu
Autor:
Frank C. Hampel, Julius van Bavel, Mark A. Wingertzahn, Patrick F. Darken, Paul H. Ratner, Tushar P. Shah
Publikováno v:
Journal of Allergy and Clinical Immunology. 118:1142-1148
Background Allergic rhinitis (AR), an inflammatory disease of the nasal mucosa, affects approximately 25% of adults and 40% of children in the United States. Ciclesonide nasal spray is a corticosteroid being developed as a hypotonic formulation for A
Autor:
Ronald A. Simon, Donald D. Stevenson
Publikováno v:
Journal of Allergy and Clinical Immunology. 118:801-804
Publikováno v:
Journal of allergy and clinical immunology, 115(5), 1017-1023. Mosby Inc.
Journal of Allergy and Clinical Immunology, 115(5), 1017-1023. Mosby Inc.
Journal of Allergy and Clinical Immunology, 115(5), 1017-1023. Mosby Inc.
Background: Steroid treatment is the mainstay of therapy for nasal polyps and rhinosinusitis. Oral steroids have considerable systemic side effects, and nasal sprays do not sufficiently reach the middle meatus, where polyps originate. Nasal drops mig
Autor:
William W. Storms
Publikováno v:
Journal of Allergy and Clinical Immunology. 114:S146-S153
Allergic rhinitis is associated with sleep disturbances, daytime somnolence, and fatigue. The exact relationship between rhinitis and sleep disturbance is unknown; however, both the symptoms and underlying pathology of allergic rhinitis can interfere
Publikováno v:
Journal of Allergy and Clinical Immunology. 139:AB65
Autor:
Glenis Scadding
Publikováno v:
Journal of Allergy and Clinical Immunology. 108:S59-S64
The goal of treatment in pediatric allergic rhinitis is to provide effective prevention of or relief from allergic rhinitis symptoms as safely and effectively as possible. Removing or avoiding allergens is always advised; however, pharmacotherapy is